Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity. [electronic resource]

By: Contributor(s): Producer: 20190704Description: 287-289 p. digitalISSN:
  • 1573-7209
Subject(s): Online resources: In: Angiogenesis vol. 20
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter; Review

There are no comments on this title.

to post a comment.